Eugene Williams - 12 Jun 2025 Form 4 Insider Report for ProMIS Neurosciences Inc. (PMN)

Reporting relationship: Director
Issuer ticker: PMN
Reported as of: 12 Jun 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 16 Jun 2025, 16:45:42 UTC
Prior SEC filing: 07 Oct 2024
Next SEC filing: 04 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Max Milbury, Attorney in Fact for Eugene Williams

Key filing fact

Eugene Williams filed Form 4 for ProMIS Neurosciences Inc. (PMN) on 16 Jun 2025.

Key facts

This page summarizes Eugene Williams's Form 4 filing for ProMIS Neurosciences Inc. (PMN).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 16 Jun 2025, 16:45.

Change

Previous filing in this sequence was filed on 07 Oct 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001927626 Primary reporting owner

Williams Eugene

Relationship: Director
Address: C/O PROMIS NEUROSCIENCES INC., SUITE 200, 1920 YONGE STREET, TORONTO, ONTARIO, CANADA
Signature: /s/ Max Milbury, Attorney in Fact for Eugene Williams
Signature date: 16 Jun 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PMN transaction Derivative

Option (right to buy)

Award

Transaction value: $0
Shares: +20,000
Change %
Price: $0.000000
Shares after: 20,000
Date: 12 Jun 2025
Ownership: Direct
Underlying class: Common Shares
Underlying amount: 20,000
Exercise price: $0.5000
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The options shall vest in full on the earlier of the first anniversary of the Grant Date and June 12, 2026, subject to continued service on the Board.